相似化合物
287944-10-9 7686-77-3 1146616-05-8欧盟法规
C&L通报上下游产品
2-cyclopent-1-enyl-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane 1-brom°Cyclopentene 2-methoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 1-(carboxymethoxy)cyclopentadiene 3,4-bis(benzyloxy)-6-(cyclopent-1-en-1-yl)pyridazine methyl 2-(tert-butoxy)-2-[3-(cyclopent-1-en-1-yl)-2-(3,4-dihydro-2H-1-benzopyran-6-yl)-6-(trifluoromethyl)phenyl] acetate 合成工艺路线路线简述
- 17497-52-8 = 850036-28-1
反应条件:1.1 Reagents: Tert-Butyllithium Solvents: Diethyl Ether,Pentane; 5 Min,-78 °C; 30 Min,-78 °C1.2 Reagents: Triisopropyl Borate Solvents: Diethyl Ether; 5 Min,-78 °C; 1 H,-78 °C; 30 Min,-78 °C -> Rt; 30 Min,Rt1.3 Reagents: Hydrochloric Acid Solvents: 1,4-Dioxane; Rt1.4 Reagents: Water; 2 H,Rt
标题:Synthesis Of Nitrodienes,Nitrostyrenes,And Nitrobiaryls Through Palladium-Catalyzed Couplings Of β-Nitrovinyl And O-Nitroaryl Thioethers
作者:Creech,Gardner S.; Et Al
参考文献:Chemical Science 日期:2013 卷标:4(6) 页码:2670-2674]
287944-10-9 = 850036-28-1
反应条件:1.1 Reagents: Ammonium Acetate,Sodium Periodate Solvents: Acetone,Water; 2 D,Rt
标题:Preparation Of α-Oxygenated Ketones By The Dioxygenation Of Alkenyl Boronic Acids
作者:Patil,Aditi S.; Et Al
参考文献:Angewandte Chemie 日期:2012 卷标:51(31) 页码:7799-7803]
287944-10-9 = 850036-28-1
反应条件:1.1 Reagents: Ammonium Acetate,Sodium Periodate Solvents: Acetone,Water; 24 - 48 H,Rt
标题:Synthesis Of 1-Vinyl/arylbenzotriazole 3-Oxides Through A Copper-Mediated C-N Bond Coupling Reaction
作者:Shi,Wei-Min; Et Al
参考文献:Advanced Synthesis & Catalysis 日期:2017 卷标:359(16) 页码:2741-2746]
17529-98-5 = 850036-28-1
反应条件:1.1 Reagents: Butyllithium,N,N,N′,N′-Tetramethylethylenediamine Solvents: Hexane; -78 °C; 1 H,-78 °C; 2 H,-78 °C -> Rt; Rt -> -78 °C1.2 Reagents: Trimethyl Borate; 2 H,-78 °C -> Rt1.3 Reagents: Water1.4 Reagents: Hydrochloric Acid Solvents: Tetrahydrofuran,Water; 2 H,Rt
标题:Pd-Catalyzed Heck-Type Reaction: Synthesizing Highly Diastereoselective And Multiple Aryl-Substituted P-Ligands
作者:Li,Chong; Et Al
参考文献:Organic Letters 日期:2019 卷标:21(17) 页码:7138-7142]
120-92-3 + 1576-35-8 = 850036-28-1
反应条件:1.1 Solvents: Methanol; Rt; 6 H,60 °C2.1 Reagents: Butyllithium,N,N,N′,N′-Tetramethylethylenediamine Solvents: Hexane; -78 °C; 1 H,-78 °C; 2 H,-78 °C -> Rt; Rt -> -78 °C2.2 Reagents: Trimethyl Borate; 2 H,-78 °C -> Rt2.3 Reagents: Water2.4 Reagents: Hydrochloric Acid Solvents: Tetrahydrofuran,Water; 2 H,Rt
标题:Pd-Catalyzed Heck-Type Reaction: Synthesizing Highly Diastereoselective And Multiple Aryl-Substituted P-Ligands
作者:Li,Chong; Et Al
参考文献:Organic Letters 日期:2019 卷标:21(17) 页码:7138-7142]
120-92-3 + 1576-35-8 = 850036-28-1
反应条件:1.1 Solvents: Methanol; 2 H,70 °C2.1 Reagents: Butyllithium,N,N,N′,N′-Tetramethylethylenediamine Solvents: Hexane; 1 H,-78 °C; -78 °C -> 25 °C; 2 H,25 °C; 25 °C -> -78 °C2.2 -78 °C2.3 Solvents: Water3.1 Reagents: Ammonium Acetate,Sodium Periodate Solvents: Acetone,Water; 24 - 48 H,Rt
标题:Synthesis Of 1-Vinyl/arylbenzotriazole 3-Oxides Through A Copper-Mediated C-N Bond Coupling Reaction
作者:Shi,Wei-Min; Et Al
参考文献:Advanced Synthesis & Catalysis 日期:2017 卷标:359(16) 页码:2741-2746]
61676-62-8 + 17529-98-5 = 850036-28-1
反应条件:1.1 Reagents: Butyllithium,N,N,N′,N′-Tetramethylethylenediamine Solvents: Hexane; 1 H,-78 °C; -78 °C -> 25 °C; 2 H,25 °C; 25 °C -> -78 °C1.2 -78 °C1.3 Solvents: Water2.1 Reagents: Ammonium Acetate,Sodium Periodate Solvents: Acetone,Water; 24 - 48 H,Rt
标题:Synthesis Of 1-Vinyl/arylbenzotriazole 3-Oxides Through A Copper-Mediated C-N Bond Coupling Reaction
作者:Shi,Wei-Min; Et Al
参考文献:Advanced Synthesis & Catalysis 日期:2017 卷标:359(16) 页码:2741-2746
环戊烯-1-羧酸甲酯置于溴,碘,Magnesium,Potassium Hydroxide体系中,用 四氢呋喃,二氯甲烷,水 作为反应溶剂,化学反应 0.5H,反应生成 环戊烯-1-基硼酸
参考文献:一种制备环戊(己)烯-1-硼酸频那醇酯的方法
标题:一种制备环戊(己)烯-1-硼酸频那醇酯的方法
摘要:本发明公开了一种从环戊(己)烯‑1‑羧酸甲酯出发,经过三步连续操作制备环戊(己)烯‑1‑硼酸频那醇酯的方法.首先原料经过碱解形成相应的烯基‑1‑羧酸;随后与溴素加成,接着在dbu或dmap存在下,同时发生消除和脱羧反应生成环戊(己)烯‑1‑溴;最后环戊(己)烯‑1‑溴,甲氧基硼酸频那醇酯在金属镁存在下一锅法成酯得到环戊(己)烯‑1‑硼酸频那醇酯.本发明所提供的工艺方法连续性强,操作简便,无需低温反应,同时也可以高纯度得到环戊(己)烯‑1‑澳中间体,满足市场上需求.一锅法格氏/酯化,操作上更便捷,副产物少,产品更容易精馏提纯.
专利信息
专利号:US-12428425-B2
优先权日:2020-05-04
标 题:Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use
发明人:CZABANIUK LARA C; HOPPER TIMOTHY; HOUZE JONATHAN B; PANTELEEV JANE; RESCOURIO GWENAELLA; SANTORA VINCENT; WANG HAOXUAN; WHITE RYAN D; WONG ALICE R; WU YONGWEI; BOS MAXENCE; MANCUSO JOHN; FRANZONI IVAN
权利人:AMGEN INC; VIGIL NEUROSCIENCE INC
摘要:The present disclosure provides compounds of Formula I, useful for the activation of Triggering Receptor Expressed on Myeloid Cells 2 (“TREM2â€?).This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a neurodegenerative disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula I.
专利号:US-8637555-B2
优先权日:2003-10-31
标题:Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
发明人:SEMPLE GRAEME; SCHRADER THOMAS; SKINNER PHILIP J; COLLETTI STEVEN L; GHARBAOUI TAWFIK; IMBRIGLIO JASON E; JUNG JAE-KYU; LIANG RUI; RAGHAVAN SUBHAREKHA; SCHMIDT DARBY; TATA JAMES R
权利人:SEMPLE GRAEME; SCHRADER THOMAS; SKINNER PHILIP J; COLLETTI STEVEN L; GHARBAOUI TAWFIK; IMBRIGLIO JASON E; JUNG JAE-KYU; LIANG RUI; RAGHAVAN SUBHAREKHA; SCHMIDT DARBY; TATA JAMES R; ARENA PHARM INC; MERCK & CO INC
摘要:The present invention relates to certain tetrazole derivatives of Formula (I), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. n nAlso provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like. In addition, the present invention also provides for the use of the compounds of the invention in combination with other active agents such as those belonging to the class of α-glucosidase inhibitors, aldose reductase inhibitors, biguanides, HMG-CoA reductase inhibitors, squalene synthesis inhibitors, fibrates, LDL catabolism enhancers, angiotensin converting enzyme (ACE) inhibitors, insulin secretion enhancers and the like.
专利号:CN-117700459-B
优先权日:2023-12-25
标题 :Synthesis and application of a type of benzo five-membered C-P ring skeleton monophosphine ligand
专利号:CN-117700459-A
优先权日:2023-12-25
标 题:Synthesis method and application of a type of benzo five-membered C-P ring skeleton monophosphine ligand